1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Refractory Visual Pathway Glioma: new trials by email Literature Review of Refractory Visual Pathway Glioma trials Research Report on Refractory Visual Pathway Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Biospecimen Collection, Selumetinib - Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 217 | 2010-07-07 | 2026-09-21 |
Astrocytoma (1) · Neurofibromatosis 1 (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Glioma (1) · Heredodegenerative Disorders, Nervous System (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neoplastic Syndromes, Hereditary (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Neurocutaneous Syndromes (1) · Neurodegenerative Diseases (1)
AZD 6244 (1) · Specimen Handling (1)
National Cancer Institute (NCI) (1)
United States (1)
U01CA081457 (1), UM1CA081457 (1)